GREENLAND MINES LTD Federal Deposit Insurance Corporation Premium Expense
GREENLAND MINES LTD (GRML) reported Federal Deposit Insurance Corporation Premium Expense of $116.60 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FederalDepositInsuranceCorporationPremiumExpense · last filed 2022-11-14
- GREENLAND MINES LTD federal deposit insurance corporation premium expense for the quarter ending 2022-09-30 was $116.60M.
- GREENLAND MINES LTD federal deposit insurance corporation premium expense for the quarter ending 2022-06-30 was -$249.88K.
- GREENLAND MINES LTD federal deposit insurance corporation premium expense for the quarter ending 2022-03-31 was $250.00K.
| Period end | Federal Deposit Insurance Corporation Premium Expense 3 month | Federal Deposit Insurance Corporation Premium Expense 6 month | Federal Deposit Insurance Corporation Premium Expense 9 month |
|---|---|---|---|
| 2022-09-30 | $116.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $116.35M derived: sum of 2 quarters · filed 2022-11-14 | $116.60M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$249.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $116.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $250.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |